CVR ENERGY INC (CVI)       30.53  +0.75 (+2.52%)

30.53  +0.75 (+2.52%)

US12662P1084 - Common Stock - After market: 30.41 -0.12 (-0.39%)


Fundamental Rating

6

Taking everything into account, CVI scores 6 out of 10 in our fundamental rating. CVI was compared to 380 industry peers in the Oil, Gas & Consumable Fuels industry. CVI has a medium financial health rating, its profitability is only medium as well. CVI has a correct valuation and a medium growth rate.




Profitability

Profitability Rating

6

CVI has a Return On Equity of 87.38%. This is amongst the best returns in the industry. The industry average is 28.11%. CVI outperforms 92% of its industry peers.
CVI has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for CVI.

CVI has a Return On Assets of 11.26%. This is comparable to the industry average of 12.84%.
CVI's Profit Margin of 4.26% is worse than the rest of the industry. The industry average Profit Margin is 25.86%. 90% of the industry peers have a better Profit Margin.
VS Industry

ROA (11.26%) VS Industry: 45% outperformed.

0.06
1,708.00

ROE (87.38%) VS Industry: 92% outperformed.

0.24
19,161.80

Profit Margin (4.26%) VS Industry: 10% outperformed.

0.07
334.14

Valuation

Valuation Rating

6

The Price/Earnings Ratio is 5.05, which indicates a rather cheap valuation of CVI.
The Forward Price/Earnings Ratio of 8.07 indicates a rather cheap valuation of CVI.
CVI's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
Compared to an average industry Price/Earning Ratio of 5.70, CVI is valued in line with its industry peers.

When comparing the current price to the book value of CVI, we can conclude it is valued correctly. It is trading at 5.78 times its book value.
Compared to an average industry Enterprise Value to EBITDA ratio of 3.65, CVI is valued in line with its industry peers.
When comparing the price book ratio of CVI to the average industry price book ratio of 1.43, CVI is valued more expensive than its industry peers. 92% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (5.05) VS Industry: 54% outperformed.

4,857.50
0.01

Price/Book (5.78) VS Industry: 8% outperformed.

3,894.73
0.04

Enterprise Value/ EBITDA (3.29) VS Industry: 55% outperformed.

235.61
0.36

Growth

Growth Rating

4

CVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 389.47%, which is quite impressive.
Measured over the past 5 years, CVI shows a very strong growth in Earnings Per Share. The EPS has been growing by 50.25% on average per year.
Looking at the last year, CVI shows a very strong growth in Revenue. The Revenue has grown by 50.46%.
Measured over the past 5 years, CVI shows a quite strong growth in Revenue. The Revenue has been growing by 12.72% on average per year.

CVI is expected to show a very negative growth in Earnings Per Share. In the coming 5 years, the EPS will decrease by -18.53% yearly.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
Based on estimates for the next 5 years, CVI will show a very negative growth in Revenue. The Revenue will decrease by -11.66% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS50.25% 18.13% 389.47% -37.44% -31.43% -35.6% -18.53%
Revenue12.72% 19.63% 50.46% -10.23% -11.66% N/A N/A

Health

Health Rating

6

An Altman-Z score of 3.65 indicates that CVI is not in any danger for bankruptcy at the moment.
The Altman-Z score of CVI is much better than the industry average of 2.07.
CVI has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for CVI.
CVI has a Current Ratio of 1.11. This is a normal value and indicates that CVI is financially healthy and should not expect problems in meeting its short term obligations.

The Current Ratio is in line with the industry averages, which is at 1.17.
CVI has a Quick Ratio of 1.11. This is a bad value and indicates that CVI is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Quick Ratio of CVI to the average industry Current Ratio of 1.03, CVI is less able to pay its short term obligations than its industry peers.
CVI has one of the worst Debt to Equity ratios in its industry. 96% of its industry peers require less debt for financing their operations.
VS Industry

Debt/Equity (2.98) VS Industry: 4% outperformed.

78.08
0.00

Quick Ratio (0.67) VS Industry: 29% outperformed.

0.00
279.52

Current Ratio (1.11) VS Industry: 46% outperformed.

0.00
279.52

Altman-Z (3.65) VS Industry: 70% outperformed.

-283,883.16
842.68

Dividend

Dividend Rating

5

With a Yearly Dividend Yield of 6.53%, CVI is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.55, CVI pays a better dividend.
CVI has paid a dividend for at least 10 years, which is a reliable track record.
Compared to an average industry Dividend Yield of 5.56, CVI has a dividend in line with its industry peers.

The dividend of CVI decreases each year by -35.99%.
CVI's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
104.09% of the earnings are spent on dividend by CVI. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (6.53%) VS Industry: 57% outperformed.

0.32
64.51

CVR ENERGY INC30.53

NYSE:CVI (3/20/2023, 8:04:00 PM)+0.75 (+2.52%)

After market: 30.41 -0.12 (-0.39%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 02-21 2023-02-21/amc Earnings (Next) 05-01 2023-05-01/amc
Inst Owners 96.3% Inst Owner Change 0.34%
Ins Owners N/A Ins Owner Change N/A
Market Cap 3.07B Analysts 47.69
Price Target 34.17 (11.92%)

Dividend
Industry RankSector Rank
Dividend Yield 6.53%
Dividend Growth(5Y) -35.99% DP 104.09%
Div Incr Years 2 Div Non Decr Years 2
Ex-Date 03-03 2023-03-03 (0.5)

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) 5.47%
Min EPS beat(2) -1.08% Max EPS beat(2) 12.01%
EPS beat(4) 2 Avg EPS beat(4) -0.61%
Min EPS beat(4) -18.94% Max EPS beat(4) 12.01%
Revenue beat(2) 2 Avg Revenue beat(2) 11.25%
Min Revenue beat(2) 11.2% Max Revenue beat(2) 11.3%
Revenue beat(4) 4 Avg Revenue beat(4) 19.97%
Min Revenue beat(4) 11.2% Max Revenue beat(4) 30.08%
PT rev (1m) -4.29% PT rev (3m) -1.47%
EPS NQ rev (1m) 39.67% EPS NQ rev (3m) 22.91%
EPS NY rev (1m) 14.6% EPS NY rev (3m) 14.6%
Revenue NQ rev (1m) 6.31% Revenue NQ rev (3m) 27.44%
Revenue NY rev (1m) 13.44% Revenue NY rev (3m) 13.44%

Valuation
Industry RankSector Rank
PE 5.05
Fwd PE 8.07
P/S 0.28
P/FCF 4.43
P/OCF 3.17
P/B 5.78
P/tB 5.78
EV/EBITDA 3.29
EPS(TTM) 6.05 EY 19.82%
EPS(NY) 3.78 Fwd EY 12.4%
FCF(TTM) 6.89 FCFY 22.58%
OCF(TTM) 9.62 OCFY 31.51%
SpS 108.38 BVpS 5.28
TBVpS 5.28 PEG (NY) N/A
PEG (5Y) 0.1

Profitability
Industry RankSector Rank
ROA 11.26%
ROE 87.38%
ROIC 29.19%
ROICexc 36.05%
ROICexgc 36.05%
OM 8.93%
PM 4.26%
GM 10.37%
ROICexgc(3y) N/A ROICexcg growth 3Y 27.45%
ROICexcg growth 5Y 62.07% ROICexc(3y) N/A
ROICexc growth 3Y 27.45% ROICexc growth 5Y 62.55%
OM growth 3Y -0.41% OM growth 5Y 37.23%
PM growth 3Y -10.72% PM growth 5Y 1.6%
GM growth 3Y -12.35% GM growth 5Y 7.28%
F-Score 8 Asset Turnover 2.65

Health
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF 2.3
Debt/EBITDA 1.26
Cap/Depr 95.14%
Profit Quality 149.35%
Current Ratio 1.11
Quick Ratio 0.67
Altman-Z 3.65
F-Score 8 WACC 10.23%
ROIC/WACC 3.52 Cap/Depr(3y) 93.01%
Cap/Depr(5y) 74.91% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 389.47% EPS 3Y 18.13%
EPS 5Y 50.25% EPS growth Q2Q 940%
EPS Next Y -37.44% EPS Next 2Y -31.43%
EPS Next 3Y -35.6% EPS Next 5Y -18.53%
Revenue growth 1Y 50.46% Revenue growth 3Y 19.63%
Revenue growth 5Y 12.72% Revenue growth Q2Q 26.83%
Revenue Next Year -10.23% Revenue Next 2Y -11.66%
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y 981.11% EBIT growth 3Y 19.14%
EBIT growth 5Y 54.68% EBIT Next Year 3.1%
EBIT Next 3Y -20.79% EBIT Next 5Y N/A
FCF growth 1Y 314.97% FCF growth 3Y 5.63%
FCF growth 5Y 70.36% OCF growth 1Y 144.19%
OCF growth 3Y 8.99% OCF growth 5Y 42.1%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA